What Is the Future of Decentralized Trials in Cancer?
The future of decentralized trials in oncology looks promising, with continuous advancements in digital health technologies. The integration of artificial intelligence (AI) and machine learning could further enhance data analytics, providing deeper insights into treatment outcomes. As more pharmaceutical companies and research institutions adopt this model, we can expect to see a transformation in how cancer treatments are developed and delivered.
